|
May 17
|
Trump administration not backing down on Big Pharma pressure campaign
|
|
May 17
|
3 Magnificent Stocks That Are Passive Income Machines
|
|
May 16
|
Jim Cramer Notes That “People Are Staying Away From” Johnson & Johnson
|
|
May 15
|
Why Is Johnson & Johnson (JNJ) Down 4.9% Since Last Earnings Report?
|
|
May 14
|
Halozyme, J&J slide as analyst cuts rating on CMS draft guidance
|
|
May 14
|
The Smartest Dividend Stocks to Buy With $5,000 Right Now
|
|
May 13
|
Is Johnson & Johnson (JNJ) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom?
|
|
May 13
|
Big Pharma Counted on This Loophole. It May Be Closing.
|
|
May 13
|
Top Biotech Halozyme Undercuts Its Breakout On Bad Medicare News
|
|
May 13
|
With the breakneck speed of cancer breakthroughs, oncologists feel left behind. Can Big Pharma chime in?
|
|
May 12
|
S&P, Dow Pharma Stocks Boomerang On Drug-Pricing Order That Is 'All Bark' And 'Little Bite'
|
|
May 12
|
HistoSonics secures first insurance coverage for histotripsy system
|
|
May 12
|
Trump expected to sign order to slash US drug prices
|
|
May 12
|
Mag 7 rally, airline & pharmaceutical stocks: Trending Tickers
|
|
May 12
|
US-China trade truce, April CPI, drug prices: 3 Things
|
|
May 12
|
Pharma Shares Fall Pre-Bell Following Plan by Trump to Reduce US Prescription Drug Prices
|
|
May 12
|
J&J reports new data from Phase III trial of icotrokinra for plaque psoriasis
|
|
Mar 29
|
Jim Cramer on Johnson & Johnson (NYSE:JNJ): Their Spinoff Was Ill-Advised
|
|
Mar 29
|
3 Relatively Safe Stocks to Buy Right Now
|
|
Mar 28
|
Sector Update: Health Care Stocks Softer Late Afternoon
|